Why Moderna Is the Biggest Winner From COVID Boosters So Far

It's been roughly three and a half months since the U.S. Food and Drug Administration (FDA) authorized boosters for the COVID-19 vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) for certain groups. Around two and half months ago, the agency granted authorizations for boosters for Moderna's (NASDAQ: MRNA) and Johnson & Johnson's (NYSE: JNJ) vaccines, with limitations for which individuals could receive the Moderna booster. 

A little over two weeks ago, the FDA broadened its Emergency Use Authorization for the Pfizer-BioNTech and Moderna boosters to include all adults ages 18 and older. Overall, close to 42 million Americans have received booster shots. 

Which vaccine maker is winning the battle of the boosters so far? It's still early, but Moderna appears to be ahead in several respects. 

Continue reading

Source Fool.com